wet- en regelgeving US FDA approves AbbVie’s oral JAK inhibitor, Rinvoq to treat rheumatoid arthritis 19 augustus 2019Pharma Biz
wet- en regelgeving Celgene’s Inrebic becomes second FDA-approved therapy for rare bone marrow disorder 19 augustus 2019InPharm.com
onderzoek Lilly’s Taltz beats Janssen’s Tremfya at Phase 4 in plaque psoriasis 15 augustus 2019InPharm.com
wet- en regelgeving Janssen chalks up two more indications in Europe for Imbruvica combo therapies 15 augustus 2019InPharm.com
